NHS England pauses new referrals for masculinising or feminising hormone treatment in under-18s

The Guardian - World NewsCenter-LeftEN 3 min read 100% complete by Andrew Gregory Health editorMarch 9, 2026 at 01:01 AM

Read Original Article

AI Summary

medium article 3 min

NHS England is pausing new referrals for masculinising or feminising hormone treatments for individuals aged 16 and 17. This decision follows a review of clinical evidence which found insufficient support for the treatment's continued use in this age group. The review was commissioned after concerns raised in the Cass review, which recommended caution in providing such treatments to those under 18. While existing patients under 18 receiving these hormones may continue treatment under individual clinical review, a 90-day public consultation has been launched to consider removing the treatment as a routine procedure. This pause comes after a previous halt to a clinical trial on puberty blockers due to concerns about potential long-term harms. The NHS is continuing to examine the evidence for hormone treatments in adults.

Key Entities & Roles

Key Player Opposition Context

James Palmer ×260% United Kingdom ×270% Hilary Cass ×275% NHS England ×795%

Keywords

hormone treatment 90% nhs england 80% under-18s 80% gender dysphoria 70% gender incongruence 70% masculinising hormones 70% feminising hormones 70% cass review 60% clinical evidence 60% puberty blockers 50%

Sentiment Analysis

Negative

Score: -0.20

Source Transparency

Source

The Guardian - World News

Political Lean

Center-Left (-0.40)

Far LeftCenterFar Right

Classification Confidence

90%

Geographic Perspective

England

This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).

Topic Connections

Explore how the topics in this article connect to other news stories

No topic relationship data available yet. This graph will appear once topic relationships have been computed.

hormone treatment nhs england under-18s gender dysphoria gender incongruence masculinising hormones feminising hormones cass review clinical evidence puberty blockers

Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.